Scilex Holding Co (SCLX) stock
SCLXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLXW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$2.57−0.26 (-9.19%)
Close on Oct 19, 2026Market cap $17.71MP/E –Yield –
Scilex shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Scilex's shares outstanding was 7M at Jun 30, 2026. For fiscal 2025 it was 0M, up 8.8% from the year before. The highest annual figure on record is 4M in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0M | +8.8% |
| FY2024 | Dec 31, 2024 | 0M | -99.7% |
| FY2023 | Dec 31, 2023 | 4M | -2.9% |
| FY2022 | Dec 31, 2022 | 4M | +1.0% |
| FY2021 | Dec 31, 2021 | 4M | +99872.2% |
| FY2020 | Dec 31, 2020 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 7M | -40.6% |
| Q1 FY2026 | Mar 31, 2026 | 7M | -40.4% |
| Q4 FY2025 | Dec 31, 2025 | 0M | +24.0% |
| Q3 FY2025 | Sep 30, 2025 | 0M | +136.8% |
| Q2 FY2025 | Jun 30, 2025 | 12M | +396174.8% |
| Q1 FY2025 | Mar 31, 2025 | 12M | +316.8% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +89.2% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +20.3% |
| Q1 FY2024 | Mar 31, 2024 | 0M | -27.7% |
| Q4 FY2023 | Dec 31, 2023 | 3M | -29.5% |
| Q3 FY2023 | Sep 30, 2023 | 0M | -99.9% |
| Q2 FY2023 | Jun 30, 2023 | 0M | -99.9% |
| Q1 FY2023 | Mar 31, 2023 | 0M | -99.9% |
| Q4 FY2022 | Dec 31, 2022 | 4M | +698.6% |
| Q3 FY2022 | Sep 30, 2022 | 4M | +672.7% |
| Q2 FY2022 | Jun 30, 2022 | 4M | +725.1% |
| Q1 FY2022 | Mar 31, 2022 | 4M | – |
| Q3 FY2021 | Sep 30, 2021 | 0M | – |
| Q2 FY2021 | Jun 30, 2021 | 0M | – |
| Q1 FY2021 | Mar 31, 2021 | 0M | – |
| Q2 FY2020 | Jun 30, 2020 | 0M | – |
See a number that looks wrong?